BUY JUVEDERM® VOLITE™ WITH LIDOCAINE ONLINE

Buy Other Juvederm Products By Clicking Here

Main Benefits

• Helps hydrate skin while reducing the look of fine lines.
• Results last up to nine months from just one treatment.
• Created with Vycross technology for a smooth, soft gel.
• Suitable for the face, neck, decolletage, and hands.

Ingredients

Hyaluronic acid 12.0 mg, Lidocaine hydrochloride 3.0 mg, and Phosphate buffer pH 7.2 q.s. 1 ml.

Ingredients Information

• Hyaluronic acid: holds moisture in the skin to restore volume and smooth the look of fine lines, and helps stimulate collagen growth for improved skin elasticity.
• Lidocaine hydrochloride: an anesthetic to numb skin for greater comfort during treatment.

Use Instructions

1. Before treatment, inform patient about product indications, contraindications, incompatibilities, and potential undesirable effects or risks, and ensure they are aware of signs and symptoms of potential complications.
2. Thoroughly disinfect treatment area.
3. The manufacturer recommends using the supplied 32 G 1/2" needle, but it is possible to use a 32 G 3/16" TSK needle. Determine needle length based on injection technique.
4. To assemble needle and syringe, first remove tip cap by pulling it straight off the syringe. Refer to product leaflet for diagrams.
5. Firmly push provided needle into syringe, screwing gently counterclockwise.
6. Twist needle again until it is fully locked and needle cap is positioned correctly.
7. Remove protective cap by holding syringe body in one hand, cap in the other hand, and pulling in opposite directions.
8. Before injecting, depress plunger rod until gel flows out of needle.
9. Inject intradermally.
10. After inserting needle and before injecting, slightly withdraw plunger to aspirate and verify the needle is not in a blood vessel.
11. Inject gel slowly and apply least amount of pressure necessary.
12. If needle is blocked, do not increase pressure. Instead, stop injecting and replace the needle. Otherwise, the needle could disengage or product could leak at luer-lock level and increase risk of vascular compromise.
13. If blanching occurs during injection, stop injecting and massage area until normal color returns.
14. Degree and duration of correction depend on treated defect, tissue stress at implant site, implant depth, and injection technique.
15. Do not overcorrect. Excessive volume may cause tissue necrosis (tissue death) and edema (swelling).
16. Massage treated area to ensure gel is uniformly distributed.
17. You may have to perform a touch up for achieving optimal correction or a repeat to maintain optimal correction. Wait at least two weeks between injections to ensure side effects resolve.
18. Properly dispose of used needles and syringes.

Precautions

• Intended for injection by qualified medical practitioners with appropriate training and experience in injection techniques and anatomy knowledge at injection site.
• Only for intra-dermal injection.
• Not for use in breast augmentation or reconstruction.
• Take into account the presence of Lidocaine in this filler.
• Do not inject in the eyelids.
• Not for intravascular injection (into blood vessels) because this could cause embolization (blocked blood vessels), vessel occlusion (blockage), ischemia (inadequate blood supply), or infarction (obstruction of blood supply causing local tissue death).
• Do not overcorrect.
• Not for use in patients who have untreated epilepsy; patients who tend to develop hypertrophic scarring; patients with a known hyaluronic acid sensitivity or gram-positive bacterial protein sensitivity since this hyaluronic acid is produced using Streptococcus-type bacteria; patients with a known Lidocaine sensitivity or amide-type local anesthetic sensitivity; or patients with porphyria.
• Not for use in pregnant patients.
• Not for use in breastfeeding patients.
• Not for use in children.
• Not for use in areas with skin inflammation or infection, such as acne and herpes.
• Not for simultaneous use with laser treatment, deep chemical peels, or dermabrasion. Do not inject this filler if there is a significant inflammatory reaction from surface peels.
• There is no clinical data about injecting into an area already treated with a filler from another brand.
• The manufacturer recommends not injecting into a site with a permanent implant.
• Injections carry an infection risk. Use standard precautions relating to injectable materials.
• There is no data regarding efficiency and tolerance of this dermal filler in patients who currently have, or have a history of, autoimmune deficiency or who are taking immunosuppressive therapy. Decide case-by-case whether to inject, depending on the nature of disease and its treatment. Specifically monitor these patients, and perform a preliminary skin test for hypersensitivity before treatment, avoiding injection if the disease is active.
• There is no data regarding tolerance in patients with a history of severe or multiple allergies. Decide case-by-case whether to inject, depending on the nature of the allergy. Specifically monitor these patients. Propose a skin test for hypersensitivity or administer suitable preventative treatment before injection. The manufacturer does not recommend injecting if there is a history of anaphylactic shock.
• Perform a skin test for hypersensitivity before injecting patients who have a history of streptococcal disease, including recurrent sore throats or acute rheumatic fever. The manufacturer does not recommend injecting if there is acute rheumatic fever with heart complications.
• Warn patients of potential increased risk of bleeding and hematomas (bruising) during injection if they are taking anti-coagulation drugs; using substances that can prolong bleeding, such as warfarin, acetylsalicylic acid, and nonsteroidal anti-inflammatory drugs; or using substances that increase coagulation time, such as herbal supplements containing garlic or ginkgo biloba.
• There is no safety data on injecting more than 20 ml of dermal fillers per 60 kg (130 lbs) body mass per year.
• Since there is Lidocaine in this filler, the manufacturer does not recommend combining with certain drugs that reduce or inhibit hepatic metabolism, such as cimetidine and beta-blockers.
• Since there is Lidocaine in this filler, use caution in patients with symptoms of cardiac conduction disorders.
• Inform patient they should not use makeup for at least twelve hours following injection.
• Inform patient they should avoid extended exposure to sun, UV, and temperatures below freezing, and sauna or hammam sessions, for at least two weeks following treatment.
• This product is compatible with magnetic resonance imaging (MRI) fields.
• The hyaluronic acid in this filler is incompatible with benzalkonium chloride and other quaternary ammonium salts. Do not allow the filler to contact these substances or medical-surgical instruments treated with these substances.
• There is no known interaction with other local anesthetics.
• Do not modify this product or it could affect sterility, homogeneity, and product performance.
• Check expiry date on product label before use.
• If syringe contents are cloudy or show signs of separation, do not use.
• Do not re-use. Sterility cannot be guaranteed.
• Do not re-sterilize.
• Do not try to straighten a bent needle. Throw away and replace.

Side Effects

• Inflammatory reactions, such as redness, edema, and erythema, possibly with itching, pain, pressure, or paresthesia (tingling). These may occur after the injections and last for a week.
• Hematomas (bruising).
• Induration (hardening) or nodules (lumps) at the injection site.
• Staining or discoloring at injection site, especially with too superficial an injection, called the Tyndall effect.
• Poor or weak filling effect.
• Rare but serious side effects after intravascular injection and tissue compression. These may include temporary or permanent vision impairment, blindness, cerebral ischemia (insufficient blood flow to the brain) or cerebral hemorrhage leading to stroke, skin necrosis (death), and damage to underlying structures. Stop injection immediately if patient has symptoms including vision changes, signs of stroke, skin blanching, or unusual pain during or soon after the injection. Ensure patient receives prompt medical attention and possibly sees a specialist if there is an intravascular injection.
• Rarely, abscesses, granuloma, and immediate or delayed hypersenstivity.

Side effects may be immediate or delayed. If side effects last more than a week, or if other side effects develop, patients should report this to their medical practitioner as soon as possible for treatment. These may not be all the possible side effects.

Frequently Asked Questions About This Product

What is it?

The hyaluronic acid in this dermal filler is created using Vycross technology for a soft, smooth consistency, and the Lidocaine helps make treatment more comfortable. Use this dermal filler to improve skin hydration and elasticity, and to reduce the look of fine lines, on the face, neck, decolletage, and hands.

When should I use this dermal filler?

The results of this dermal filler usually last about six to nine months.

• You should administer injections about once or twice a year to maintain the results.
• This skin-rejuvenating injection requires only one treatment session each time, not a series of treatments.

Why do doctors use this dermal filler?

Dermatologists, plastic surgeons, and other doctors use this dermal filler to rejuvenate the look of aging skin. This hyaluronic acid injectable can help reduce the look of fine lines while rehydrating skin and improving skin elasticity. Use this injectable on the face, neck, decolletage, or hands.

How does it work?

This dermal filler contains hyaluronic acid, which holds moisture within the skin. This increases volume to reduce the look of wrinkles. Hyaluronic acid can also help stimulate collagen growth, improving skin elasticity.

When and how do I use it?

Administer these injections about once or twice a year to maintain the treatment results. Inject this filler into the dermis.

1. Inject this filler about every six to nine months.
2. Inject using a needle.
3. Administer intradermally.

Can this dermal filler be combined with other treatments?

Do not inject this filler into a location with a permanent implant. The effect of combining different brands of dermal fillers is unknown.

How do I store it?

Store between 2° C and 25° C. Fragile.

Where can I buy it?

You can buy this injectable at Doctor Medica by choosing a quantity and adding to cart. You can also phone a helpful customer service associate to order this dermal filler or other cosmetic and medical supplies.

Through doctormedica.co, cosmetic and orthopaedic medications are offered wholesale to licensed practitioners, clinics and hospitals. Go to doctormedica.co, call 1-866-343-2413, or e-mail info@doctormedica.co for more information.

*Doctor Medica offers only genuine products manufactured by Allergan. All brands listed here are the trademarks of their respective owners and Doctor Medica is not affiliated with them in any way.